VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 32 filers reported holding VERA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,127,020 | -3.0% | 738,567 | +13.5% | 0.00% | 0.0% |
| Q2 2023 | $10,443,606 | +180.4% | 650,692 | +35.5% | 0.00% | – |
| Q1 2023 | $3,725,149 | +74792.4% | 480,045 | +86.7% | 0.00% | -100.0% |
| Q4 2022 | $4,974 | -99.9% | 257,066 | +7.2% | 0.00% | 0.0% |
| Q3 2022 | $5,110,000 | +83.5% | 239,800 | +17.2% | 0.00% | – |
| Q2 2022 | $2,784,000 | -41.5% | 204,588 | +1.0% | 0.00% | -100.0% |
| Q1 2022 | $4,757,000 | +46.5% | 202,547 | +66.6% | 0.00% | – |
| Q4 2021 | $3,248,000 | +161.5% | 121,582 | +69.8% | 0.00% | – |
| Q3 2021 | $1,242,000 | +483.1% | 71,608 | +345.4% | 0.00% | – |
| Q2 2021 | $213,000 | – | 16,076 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,960,231 | $40,289,000 | 12.90% |
| Kynam Capital Management, LP | 1,522,712 | $20,724,000 | 5.29% |
| Sofinnova Investments, Inc. | 3,181,442 | $43,299,000 | 3.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,825 | $281,057,000 | 2.93% |
| Octagon Capital Advisors LP | 575,000 | $7,826,000 | 2.09% |
| Vivo Capital, LLC | 666,666 | $9,073,000 | 0.91% |
| RA Capital Management | 1,578,820 | $21,488,000 | 0.57% |
| Alphabet Inc. | 301,580 | $4,105,000 | 0.22% |
| CARNEGIE MELLON UNIVERSITY | 16,060 | $219,000 | 0.11% |
| Polar Asset Management Partners Inc. | 294,300 | $4,005,000 | 0.05% |